Key Documents

View All Documentation

D141003

2-(Dimethylamino)ethanethiol hydrochloride

Name: 2-(Dimethylamino)ethanethiol hydrochloride
Brand: ALDRICH

95%

Synonym(s):

MEDA

Select a Size

Change View

About This Item

Linear Formula:

(CH₃)₂NCH₂CH₂SH · HCl

CAS Number:

13242-44-9

Molecular Weight:

141.66

UNSPSC Code:

12352100

NACRES:

NA.22

PubChem Substance ID:

24893430

EC Number:

236-221-6

Beilstein/REAXYS Number:

3906670

MDL number:

MFCD00012633

Assay:

95%

Form:

solid

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

Quality Level

200

assay

95%

form

solid

mp

150-160 °C (lit.)

SMILES string

Cl.CN(C)CCS

InChI

1S/C4H11NS.ClH/c1-5(2)3-4-6;/h6H,3-4H2,1-2H3;1H

InChI key

NRVFDGZJTPCULU-UHFFFAOYSA-N

Description

Application

2-(Dimethylamino)ethanethiol hydrochloride can be used:

To synthesize fluorescent thiocholine esters containing dansyl group in the acyl portions, which are potent substrates for the human fibrinoligase.
As a cationic ligand for the surface modification of gold nanoparticles.
For the modification of cellulose 10-undecenoyl ester (CUE) to form organo-soluble ionic cellulose derivatives.

Metal-complexing agent

Storage Class

11 - Combustible Solids

wgk

WGK 3

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

监管及禁止进口产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Stimuli-responsive nanoparticles from ionic cellulose derivatives

Wang Y

Nanoscale, 8(1), 648-657 (2016)

Methods report: European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC.

C Dressler et al.

Journal of the European Academy of Dermatology and Venereology : JEADV, 31(12), 1964-1977 (2017-09-26)

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG.

Peyman Hadji et al.

Journal of bone oncology, 7, 1-12 (2017-04-18)

Several guidelines have been reported for bone-directed treatment in women with early breast cancer (EBC) for averting fractures, particularly during aromatase inhibitor (AI) therapy. Recently, a number of studies on additional fracture related risk factors, new treatment options as well

View All Related Papers

Global Trade Item Number

SKU	GTIN
D141003-100G	04061832423074
D141003-25G	04061832423081